These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32091624)

  • 1. Association between cell-free DNA fetal fraction and gestational diabetes.
    Hopkins MK; Koelper N; Bender W; Durnwald C; Sammel M; Dugoff L
    Prenat Diagn; 2020 May; 40(6):724-727. PubMed ID: 32091624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequencing shorter cfDNA fragments improves the fetal DNA fraction in noninvasive prenatal testing.
    Qiao L; Yu B; Liang Y; Zhang C; Wu X; Xue Y; Shen C; He Q; Lu J; Xiang J; Li H; Zheng Q; Wang T
    Am J Obstet Gynecol; 2019 Oct; 221(4):345.e1-345.e11. PubMed ID: 31125545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low Fetal Fraction and Birth Weight in Women with Negative First-Trimester Cell-Free DNA Screening.
    Clapp MA; Berry M; Shook LL; Roberts PS; Goldfarb IT; Bernstein SN
    Am J Perinatol; 2020 Jan; 37(1):86-91. PubMed ID: 31739367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Maternal and Fetal Characteristics on Cell-Free Fetal DNA Fraction in Maternal Plasma.
    Zhou Y; Zhu Z; Gao Y; Yuan Y; Guo Y; Zhou L; Liao K; Wang J; Du B; Hou Y; Chen Z; Chen F; Zhang H; Yu C; Zhao L; Lau TK; Jiang F; Wang W
    Reprod Sci; 2015 Nov; 22(11):1429-35. PubMed ID: 25963912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity and no call results: optimal timing of cell-free DNA testing and redraw.
    Hopkins MK; Koelper N; Caldwell S; Dyr B; Dugoff L
    Am J Obstet Gynecol; 2021 Oct; 225(4):417.e1-417.e10. PubMed ID: 33839096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal fraction of cell-free DNA in noninvasive prenatal testing and adverse pregnancy outcomes: a nationwide retrospective cohort study of 56,110 pregnant women.
    Becking EC; Scheffer PG; Henrichs J; Bax CJ; Crombag NMTH; Weiss MM; Macville MVE; Van Opstal D; Boon EMJ; Sistermans EA; Henneman L; Schuit E; Bekker MN
    Am J Obstet Gynecol; 2024 Aug; 231(2):244.e1-244.e18. PubMed ID: 38097030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterine fibroids and non-informative cell-free DNA screening results.
    Rolnik DL; Raymond Y; Lee T; Ramkrishna J; da Silva Costa F; Menezes M; Meagher S
    Ultrasound Obstet Gynecol; 2024 Oct; 64(4):463-469. PubMed ID: 39177335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Fetal Fraction of Cell-Free DNA and Hypertensive Disorders of Pregnancy.
    Bender WR; Koelper NC; Sammel MD; Dugoff L
    Am J Perinatol; 2019 Feb; 36(3):311-316. PubMed ID: 30081397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Fetal Fraction on First Trimester Cell-Free DNA Aneuploidy Screening and Adverse Pregnancy Outcomes.
    Shook LL; Clapp MA; Roberts PS; Bernstein SN; Goldfarb IT
    Am J Perinatol; 2020 Jan; 37(1):8-13. PubMed ID: 31365936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weight retention at six weeks postpartum and the risk of gestational diabetes mellitus in a second pregnancy.
    Liu J; Song G; Meng T; Zhao G; Guo S
    BMC Pregnancy Childbirth; 2019 Aug; 19(1):272. PubMed ID: 31370816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gestational diabetes mellitus diagnosed at 24 to 28 weeks of gestation in older and obese Women: Is it too late?
    Kim W; Park SK; Kim YL
    PLoS One; 2019; 14(12):e0225955. PubMed ID: 31841546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-trimester screening for trisomies by cfDNA testing of maternal blood in singleton and twin pregnancies: factors affecting test failure.
    Galeva S; Gil MM; Konstantinidou L; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Jun; 53(6):804-809. PubMed ID: 30977206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal obesity and dyslipidemia associated with gestational diabetes mellitus (GDM).
    O'Malley EG; Reynolds CME; Killalea A; O'Kelly R; Sheehan SR; Turner MJ
    Eur J Obstet Gynecol Reprod Biol; 2020 Mar; 246():67-71. PubMed ID: 31962258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of first trimester fetal heart rate in the prediction of gestational diabetes: A multicenter study.
    Sirico A; Lanzone A; Mappa I; Sarno L; Słodki M; Pitocco D; Zullo F; Maruotti GM; Rizzo G
    Eur J Obstet Gynecol Reprod Biol; 2019 Dec; 243():158-161. PubMed ID: 31706055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of fetal gender and maternal characteristics on fetal cell-free DNA in maternal plasma.
    Zhao Q; HuoJiaBieKe J; Du S
    J Gynecol Obstet Hum Reprod; 2019 Oct; 48(8):653-656. PubMed ID: 31276844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of Body Mass Index on Fetal Fraction Increase With Gestation and Cell-Free DNA Test Failure.
    Rolnik DL; Yong Y; Lee TJ; Tse C; McLennan AC; da Silva Costa F
    Obstet Gynecol; 2018 Aug; 132(2):436-443. PubMed ID: 29995742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between low fetal fraction of cell free DNA at the early second-trimester and adverse pregnancy outcomes.
    Yuan X; Zhou L; Zhang B; Wang H; Yu B; Xu J
    Pregnancy Hypertens; 2020 Oct; 22():101-108. PubMed ID: 32777709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting cell-free DNA fetal fraction: statistical analysis of 13,661 maternal plasmas for non-invasive prenatal screening.
    Hou Y; Yang J; Qi Y; Guo F; Peng H; Wang D; Wang Y; Luo X; Li Y; Yin A
    Hum Genomics; 2019 Dec; 13(1):62. PubMed ID: 31801621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A fetal fraction enrichment method reduces false negatives and increases test success rate of fetal chromosome aneuploidy detection in early pregnancy loss.
    Qiao L; Zhang B; Wu X; Zhang C; Xue Y; Tang H; Tang H; Shi J; Liang Y; Yu B; Wang T
    J Transl Med; 2022 Aug; 20(1):345. PubMed ID: 35918754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of maternal autoimmune disease on cell-free DNA test characteristics.
    MacKinnon HJ; Kolarova TR; Katz R; Hedge JM; Vinopal E; Lockwood CM; Shree R; Delaney S
    Am J Obstet Gynecol MFM; 2021 Nov; 3(6):100466. PubMed ID: 34418590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.